Allergan fights back in pharma deals frenzy

Battle lines drawn in deal frenzy gripping the industry as Botox-maker adopts ‘poison pill’ defence in an effort to stifle unsolicited $48bn bid

Leave a Reply

Your email address will not be published. Required fields are marked *